178 related articles for article (PubMed ID: 18927435)
1. Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.
Becker PS; Kopecky KJ; Wilks AN; Chien S; Harlan JM; Willman CL; Petersdorf SH; Stirewalt DL; Papayannopoulou T; Appelbaum FR
Blood; 2009 Jan; 113(4):866-74. PubMed ID: 18927435
[TBL] [Abstract][Full Text] [Related]
2. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
[TBL] [Abstract][Full Text] [Related]
3. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.
Matsunaga T; Takemoto N; Sato T; Takimoto R; Tanaka I; Fujimi A; Akiyama T; Kuroda H; Kawano Y; Kobune M; Kato J; Hirayama Y; Sakamaki S; Kohda K; Miyake K; Niitsu Y
Nat Med; 2003 Sep; 9(9):1158-65. PubMed ID: 12897778
[TBL] [Abstract][Full Text] [Related]
4. VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.
Bae MH; Oh SH; Park CJ; Lee BR; Kim YJ; Cho YU; Jang S; Lee JH; Kim N; Park SH; Lim JH; Seo EJ; Lee KH
Ann Hematol; 2015 Oct; 94(10):1631-8. PubMed ID: 26155911
[TBL] [Abstract][Full Text] [Related]
5. CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity.
Gutjahr JC; Bayer E; Yu X; Laufer JM; Höpner JP; Tesanovic S; Härzschel A; Auer G; Rieß T; Salmhofer A; Szenes E; Haslauer T; Durand-Onayli V; Ramspacher A; Pennisi SP; Artinger M; Zaborsky N; Chigaev A; Aberger F; Neureiter D; Pleyer L; Legler DF; Orian-Rousseau V; Greil R; Hartmann TN
Haematologica; 2021 Aug; 106(8):2102-2113. PubMed ID: 32616529
[TBL] [Abstract][Full Text] [Related]
6. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis.
Weber C; Alon R; Moser B; Springer TA
J Cell Biol; 1996 Aug; 134(4):1063-73. PubMed ID: 8769427
[TBL] [Abstract][Full Text] [Related]
7. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms.
Bendall LJ; Kortlepel K; Gottlieb DJ
Blood; 1993 Nov; 82(10):3125-32. PubMed ID: 7693037
[TBL] [Abstract][Full Text] [Related]
8. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5.
Hart R; Greaves DR
J Immunol; 2010 Sep; 185(6):3728-39. PubMed ID: 20720202
[TBL] [Abstract][Full Text] [Related]
9. Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins.
Kortlepel K; Bendall LJ; Gottlieb DJ
Leukemia; 1993 Aug; 7(8):1174-9. PubMed ID: 8350618
[TBL] [Abstract][Full Text] [Related]
10. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
[TBL] [Abstract][Full Text] [Related]
11. Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical Applications.
Zucchetto A; Tissino E; Chigaev A; Hartmann TN; Gattei V
Methods Mol Biol; 2019; 1881():101-112. PubMed ID: 30350200
[TBL] [Abstract][Full Text] [Related]
12. Influence of beta 1 integrin intracytoplasmic domains in the regulation of VLA-4-mediated adhesion of human T cells to VCAM-1 under flow conditions.
Rosenthal-Allieri MA; Ticchioni M; Breittmayer JP; Shimizu Y; Bernard A
J Immunol; 2005 Jul; 175(2):1214-23. PubMed ID: 16002725
[TBL] [Abstract][Full Text] [Related]
13. Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results.
Machaczka M; Wahlin BE; Piatkowska-Jakubas B; Rucinska M; Jurczak W; Balana-Nowak A; Klimkowska M; Hägglund H; Skotnicki AB
Med Oncol; 2012 Sep; 29(3):2070-6. PubMed ID: 21861206
[TBL] [Abstract][Full Text] [Related]
14. High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
Walter RB; Alonzo TA; Gerbing RB; Ho PA; Smith FO; Raimondi SC; Hirsch BA; Gamis AS; Franklin JL; Hurwitz CA; Loken MR; Meshinchi S
J Clin Oncol; 2010 Jun; 28(17):2831-8. PubMed ID: 20421533
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.
Matsunaga T; Fukai F; Miura S; Nakane Y; Owaki T; Kodama H; Tanaka M; Nagaya T; Takimoto R; Takayama T; Niitsu Y
Leukemia; 2008 Feb; 22(2):353-60. PubMed ID: 17972943
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
Mahlknecht U; Schönbein C
Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
Bendall LJ; Kortlepel K; Gottlieb DJ
Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
[TBL] [Abstract][Full Text] [Related]
18. Characterization of VLA-4-dependent myeloma cell adhesion to fibronectin and VCAM-1.
Sanz-Rodríguez F; Ruiz-Velasco N; Pascual-Salcedo D; Teixidó J
Br J Haematol; 1999 Dec; 107(4):825-34. PubMed ID: 10606891
[TBL] [Abstract][Full Text] [Related]
19. [Molecular targeting therapy by anti-VLA-4 monoclonal antibodies for AML].
Niitsu Y; Matsunaga T
Rinsho Ketsueki; 2005 Mar; 46(3):198-201. PubMed ID: 16447714
[No Abstract] [Full Text] [Related]
20. FLT3/ ITD regulates leukaemia cell adhesion through α4β1 integrin and Pyk2 signalling.
Katsumi A; Kiyoi H; Abe A; Tanizaki R; Iwasaki T; Kobayashi M; Matsushita T; Kaibuchi K; Senga T; Kojima T; Kohno T; Hamaguchi M; Naoe T
Eur J Haematol; 2011 Mar; 86(3):191-8. PubMed ID: 21114537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
